Governor Jerry Brown signed the bill, but will it actually lower drug costs?
When FluMIst was discontinued, there were worries that flu vaccination rates would drop.
Kiriko is recalling all lots of its weight-loss supplement.
A study finds that a significant number of FDA-mandated studies are unfinished.
Medical cannabis classes will no longer be held at the University of Maryland-Baltimore.
A pharmacy organization says all health-providers need to help prevent and fight antimicrobial resistance.
FDA issues new communication about risk of liver injury with Ocaliva (obeticholic acid).
A new communication says benzodiazepines can be used with buprenorphine or methadone, if carefully managed.
New data show that health benefit costs in 2018 will rise by their highest since 2011.
Gottlieb says that changes may be coming, but remains firm on current regulations.